Resorcinolnaphthalein is used as a research tool for hypertension and renal fibrosis; it acts as a specific angiotensin-converting enzyme 2 (ACE2) activator, enhancing ACE2 activity with an EC50 of 19.5 μM; it has beneficial effects on the cardiovascular system and protects against hypertension-induced pathophysiology by attenuating fibrosis and structural remodeling.